This inventor holds 1 USPTO granted patent. Top assignees: B&a Therapeutics, Fondazione Istituto Italiano Di Tecnologia. Active years: 2017.
Company Filing History:
1 out of 2 
1 out of 146 
Years Active: 2017
Title: Andrea Constestabile: Innovator in Down Syndrome Treatment
Introduction
Andrea Constestabile is a notable inventor based in Genoa, Italy. He has made significant contributions to the field of medical science, particularly in the treatment of Down syndrome. His innovative approach focuses on modulating intracellular chloride concentration, which has the potential to improve the quality of life for individuals affected by this condition.
Latest Patents
Constestabile holds a patent titled "Modulators of intracellular chloride concentration for treating Down syndrome." This invention relates to a modulator of a chloride transporter that can be utilized in the treatment of Down syndrome. The patent represents a significant advancement in therapeutic options for this genetic disorder.
Career Highlights
Throughout his career, Andrea Constestabile has worked with esteemed organizations such as the Fondazione Istituto Italiano Di Tecnologia and B&A Therapeutics. His work in these institutions has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical treatments.
Collaborations
Constestabile has collaborated with notable professionals in his field, including Yehezkel Ben-Ari and Laura Cancedda. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Andrea Constestabile's contributions to the treatment of Down syndrome through his innovative patent highlight the importance of research and collaboration in medical science. His work continues to inspire advancements in therapeutic approaches for genetic disorders.